What do You Think of CPhI? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

What do You Think of CPhI?


CPhI 2012 will draw to a close later today in Madrid. the PharmTech team hope you had a successful show!

Throughout the week, we have been asking what you thought of this year's event. Here is a quick selection are some of the comments we received:

"Very busy show, but very successful and lovely warm weather."

"Crowded, but that's to be expected. Very spread out but meetings have been a success."

"Good foot fall at our stand and great response to our products. The invstment has paid off."

"My first CPhI; very overwhelming and much busier than I expected!"

"It's been successful, as usual for our company, but I'm looking forward to going home."

You can keep up to date with any last minute news and announcements via our Twitter feed @PharmTechGroup.

Or take a look at our archive of CPhI news and announcmenets here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here